Works by la Fougere, Christian


Results: 163
    1
    2
    3

    Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM).

    Published in:
    2018
    By:
    • Nensa, Felix;
    • Bamberg, Fabian;
    • Rischpler, Christoph;
    • Menezes, Leon;
    • Poeppel, Thorsten D.;
    • la Fougère, Christian;
    • Beitzke, Dietrich;
    • Rasul, Sazan;
    • Loewe, Christian;
    • Nikolaou, Konstantin;
    • Bucerius, Jan;
    • Kjaer, Andreas;
    • Gutberlet, Matthias;
    • Prakken, Niek H.;
    • Vliegenthart, Rozemarijn;
    • Slart, Riemer H. J. A.;
    • Nekolla, Stephan G.;
    • Lassen, Martin L.;
    • Pichler, Bernd J.;
    • Schlosser, Thomas
    Publication type:
    journal article
    4
    5
    6

    [18F]Fluoride Positron-Emission Tomography (PET) and [18F]FDG PET for Assessment of Osteomyelitis of the Jaw in Comparison to Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): A Prospective PET/CT and PET/MRI Pilot Study.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 14, p. 3998, doi. 10.3390/jcm11143998
    By:
    • Reinert, Christian Philipp;
    • Pfannenberg, Christina;
    • Dittmann, Helmut;
    • Gückel, Brigitte;
    • la Fougère, Christian;
    • Nikolaou, Konstantin;
    • Hoefert, Sebastian
    Publication type:
    Article
    7

    Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52937-8
    By:
    • Hofmann, Anna;
    • Häsler, Lisa M.;
    • Lambert, Marius;
    • Kaeser, Stephan A.;
    • Gräber-Sultan, Susanne;
    • Obermüller, Ulrike;
    • Kuder-Buletta, Elke;
    • la Fougere, Christian;
    • Laske, Christoph;
    • Vöglein, Jonathan;
    • Levin, Johannes;
    • Fox, Nick C.;
    • Ryan, Natalie S.;
    • Zetterberg, Henrik;
    • Llibre-Guerra, Jorge J.;
    • Perrin, Richard J.;
    • Ibanez, Laura;
    • Schofield, Peter R.;
    • Brooks, William S.;
    • Day, Gregory S.
    Publication type:
    Article
    8
    9
    10

    <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study).

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1925, doi. 10.2967/jnumed.123.266125
    By:
    • Rahbar, Kambiz;
    • Essler, Markus;
    • Eiber, Matthias;
    • la Fougère, Christian;
    • Prasad, Vikas;
    • Fendler, Wolfgang P.;
    • Rassek, Philipp;
    • Hasa, Ergela;
    • Dittmann, Helmut;
    • Bundschuh, Ralph A.;
    • Pabst, Kim M.;
    • Kurtinecz, Milena;
    • Schmall, Anja;
    • Verholen, Frank;
    • Sartor, Oliver
    Publication type:
    Article
    11
    12

    Safety and Survival Outcomes of <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior <sup>223</sup>Ra treatment: The RALU Study.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 574, doi. 10.2967/jnumed.122.264456
    By:
    • Rahbar, Kambiz;
    • Essler, Markus;
    • Pabst, Kim M.;
    • Eiber, Matthias;
    • la Fougère, Christian;
    • Prasad, Vikas;
    • Rassek, Philipp;
    • Hasa, Ergela;
    • Dittmann, Helmut;
    • Bundschuh, Ralph A.;
    • Fendler, Wolfgang P.;
    • Kurtinecz, Milena;
    • Schmall, Anja;
    • Verholen, Frank;
    • Sartor, Oliver
    Publication type:
    Article
    13

    First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 337, doi. 10.2967/jnumed.122.264626
    By:
    • Trautwein, Nils Florian;
    • Reischl, Gerald;
    • Seitz, Christian;
    • Dittmann, Helmut;
    • Seith, Ferdinand;
    • Scheuermann, Sophia;
    • Feuchtinger, Tobias;
    • Dombrowski, Frank;
    • Handgretinger, Rupert;
    • Fuchs, Jörg;
    • Pichler, Bernd;
    • la Fougère, Christian;
    • Schwenck, Johannes
    Publication type:
    Article
    14

    First in human PET/MRI imaging of in vivo GD2 expression in osteosarcoma.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264626
    By:
    • Trautwein, Nils Florian;
    • Reischl, Gerald;
    • Seitz, Christian;
    • Dittmann, Helmut;
    • Seith, Ferdinand;
    • Scheuermann, Sophia;
    • Feuchtinger, Tobias;
    • Dombrowski, Frank;
    • Handgretinger, Rupert;
    • Fuchs, Jörg;
    • Pichler, Bernd;
    • Fougère, Christian la;
    • Schwenck, Johannes
    Publication type:
    Article
    15

    Antibody-Guided Molecular Imaging of Aspergillus Lung Infections in Leukemia Patients.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263251
    By:
    • Schwenck, Johannes;
    • Maurer, Andreas;
    • Beziere, Nicolas;
    • Fiz, Francesco;
    • Boschetti, Frederic;
    • Geistlich, Susanne;
    • Seyfried, Dominik;
    • Gunzer, Matthias;
    • Reischl, Gerald;
    • Wehrmüller, Jöri;
    • Ehrlichmann, Walter;
    • Horger, Marius;
    • Gatidis, Sergios;
    • Davies, Genna;
    • Vogel, Wichard;
    • la Fougère, Christian;
    • Pichler, Bernd;
    • Thornton, Christopher
    Publication type:
    Article
    16

    First in human PET/MRI imaging of in vivo GD2 expression in osteosarcoma.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264626
    By:
    • Trautwein, Nils Florian;
    • Reischl, Gerald;
    • Seitz, Christian;
    • Dittmann, Helmut;
    • Seith, Ferdinand;
    • Scheuermann, Sophia;
    • Feuchtinger, Tobias;
    • Dombrowski, Frank;
    • Handgretinger, Rupert;
    • Fuchs, Jörg;
    • Pichler, Bernd;
    • la Fougère, Christian;
    • Schwenck, Johannes
    Publication type:
    Article
    17

    Antibody-Guided Molecular Imaging of Aspergillus Lung Infections in Leukemia Patients.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263251
    By:
    • Schwenck, Johannes;
    • Maurer, Andreas;
    • Beziere, Nicolas;
    • Fiz, Francesco;
    • Boschetti, Frederic;
    • Geistlich, Susanne;
    • Seyfried, Dominik;
    • Gunzer, Matthias;
    • Reischl, Gerald;
    • Wehrm€uller, J€ori;
    • Ehrlichmann, Walter;
    • Horger, Marius;
    • Gatidis, Sergios;
    • Davies, Genna;
    • Vogel, Wichard;
    • la Fougere, Christian;
    • Pichler, Bernd;
    • Thornton, Christopher
    Publication type:
    Article
    18

    Brief communication: Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262240
    By:
    • Sartor, Oliver;
    • Fougère, Christian la;
    • Essler, Markus;
    • Ezziddin, Samer;
    • Kramer, Gero;
    • Ellinger, Jörg;
    • Nordquist, Luke;
    • Sylvester, John;
    • Paganelli, Giovanni;
    • Peer, Avivit;
    • Bögemann, Martin;
    • Meltzer, Jeffrey;
    • Sandström, Per;
    • Verholen, Frank;
    • Song, Daniel Y.
    Publication type:
    Article
    19
    20
    21
    22

    Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262240
    By:
    • Sartor, Oliver;
    • la Fougère, Christian;
    • Essler, Markus;
    • Ezziddin, Samer;
    • Kramer, Gero;
    • Ellinger, Jörg;
    • Nordquist, Luke;
    • Sylvester, John;
    • Paganelli, Giovanni;
    • Peer, Avivit;
    • Bögemann, Martin;
    • Meltzer, Jeffrey;
    • Sandström, Per;
    • Verholen, Frank;
    • Song, Daniel Y.
    Publication type:
    Article
    23

    Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262240
    By:
    • Sartor, Oliver;
    • la Fougère, Christian;
    • Essler, Markus;
    • Ezziddin, Samer;
    • Kramer, Gero;
    • Ellinger, Jörg;
    • Nordquist, Luke;
    • Sylvester, John;
    • Paganelli, Giovanni;
    • Peer, Avivit;
    • Bögemann, Martin;
    • Meltzer, Jeffrey;
    • Sandström, Per;
    • Verholen, Frank;
    • Song, Daniel Y.
    Publication type:
    Article
    24
    25
    26
    27

    Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262240
    By:
    • Sartor, Oliver;
    • Fougère, Christian la;
    • Essler, Markus;
    • Ezziddin, Samer;
    • Kramer, Gero;
    • Ellinger, Jörg;
    • Nordquist, Luke;
    • Sylvester, John;
    • Paganelli, Giovanni;
    • Peer, Avivit;
    • Bögemann, Martin;
    • Meltzer, Jeffrey;
    • Sandström, Per;
    • Verholen, Frank;
    • Song, Daniel Y.
    Publication type:
    Article
    28
    29
    30

    Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262240
    By:
    • Sartor, Oliver;
    • la Fougère, Christian;
    • Essler, Markus;
    • Ezziddin, Samer;
    • Kramer, Gero;
    • Ellinger, Jörg;
    • Nordquist, Luke;
    • Sylvester, John;
    • Paganelli, Giovanni;
    • Peer, Avivit;
    • Bögemann, Martin;
    • Meltzer, Jeffrey;
    • Sandström, Per;
    • Verholen, Frank;
    • Song, Daniel Y.
    Publication type:
    Article
    31
    32
    33
    34

    Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262240
    By:
    • Sartor, Oliver;
    • la Fougère, Christian;
    • Essler, Markus;
    • Ezziddin, Samer;
    • Kramer, Gero;
    • Ellinger, Jörg;
    • Nordquist, Luke;
    • Sylvester, John;
    • Paganelli, Giovanni;
    • Peer, Avivit;
    • Bögemann, Martin;
    • Meltzer, Jeffrey;
    • Sandström, Per;
    • Verholen, Frank;
    • Song, Daniel Y.
    Publication type:
    Article
    35
    36
    37

    Lutetium-177--prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.262240
    By:
    • Sartor, Oliver;
    • la Fougère, Christian;
    • Essler, Markus;
    • Ezziddin, Samer;
    • Kramer, Gero;
    • Ellinger, Jörg;
    • Nordquist, Luke;
    • Sylvester, John;
    • Paganelli, Giovanni;
    • Peer, Avivit;
    • Bögemann, Martin;
    • Meltzer, Jeffrey;
    • Sandström, Per;
    • Verholen, Frank;
    • Song, Daniel Y.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50